Target engagement asks whether a drug reaches and interacts with its intended target in the tested setting. The effect on the cell and the benefit of treatment need their own measurements.
The cellular thermal shift assay introduced a way to assess drug-associated changes in protein stability in cells and tissues as evidence of target engagement. The original work examined binding, transport, activation and resistance in defined systems. Engagement evidence must be interpreted within the assay used. It does not by itself demonstrate that the target is required for cancer-cell survival or that the drug's cellular effect is caused by acting on that target.
Shares Experimental and clinical drug exposure, Evidence from measurement to patient benefit.
Shares Experimental and clinical drug exposure, Evidence from measurement to patient benefit.
Shares Antibody internalization and intracellular trafficking, Evidence from measurement to patient benefit.
Shares Antibody internalization and intracellular trafficking, Evidence from measurement to patient benefit.
Shares Experimental and clinical drug exposure, Evidence from measurement to patient benefit.
Shares Functional evidence for a sequence variant, Evidence from measurement to patient benefit.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/